Creating New Opportunities for Value
Materia's Grubbs Catalyst® technology provides pharmaceutical companies with powerful tools for the efficient synthesis of novel drug-like compounds. Our catalysts help pharmaceutical companies lower costs, reduce development timelines, generate complex molecules quickly and ultimately generate greater profits. Having generated significant momentum in the industry, Grubbs Catalyst technology is used by nearly every major pharmaceutical company worldwide.
Addressing Today's Industry Challenges
Pharmaceutical companies face increasing pressure to enhance R&D productivity in the face of challenging molecular targets.
Grubbs Catalyst technology targets these industry challenges with value-added solutions at each phase of the drug development and commercialization process and provides robust and scalable access to synthetically challenging classes of compounds whose therapeutic potential is just beginning to be realized.